Search by Drug Name or NDC

    NDC 68968-0172-07 SECUADO 3.8 mg/d Details

    SECUADO 3.8 mg/d

    SECUADO is a TRANSDERMAL FILM, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Noven Therapeutics, LLC. The primary component is ASENAPINE.

    Product Information

    NDC 68968-0172
    Product ID 68968-0172_f98aaf2b-9c84-489d-9693-49b246c37aac
    Associated GPIs 59155015008520
    GCN Sequence Number 080406
    GCN Sequence Number Description asenapine PATCH TD24 3.8MG/24HR TRANSDERM
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 47229
    HICL Sequence Number 046175
    HICL Sequence Number Description ASENAPINE
    Brand/Generic Brand
    Proprietary Name SECUADO
    Proprietary Name Suffix n/a
    Non-Proprietary Name ASENAPINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form FILM, EXTENDED RELEASE
    Route TRANSDERMAL
    Active Ingredient Strength 3.8
    Active Ingredient Units mg/d
    Substance Name ASENAPINE
    Labeler Name Noven Therapeutics, LLC
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212268
    Listing Certified Through 2024-12-31

    Package

    NDC 68968-0172-07 (68968017207)

    NDC Package Code 68968-0172-7
    Billing NDC 68968017207
    Package 7 POUCH in 1 CARTON (68968-0172-7) / 1 d in 1 POUCH
    Marketing Start Date 2020-02-12
    NDC Exclude Flag N
    Pricing Information N/A